AbbVie is ending development of an IL-1 asset as a monotherapy in ulcerative colitis (UC) after a phase 2 study revealed ...

The interaction between a common gene variant and gut microbes may trigger chronic inflammation in ulcerative colitis, new ...

About 2.7 million people in the U.S. live with inflammatory bowel diseases, which cause long-term inflammation in the ...

IBD flare-ups can affect your daily life. Ways to manage these flare-ups may include stress management, dietary changes, ...

Shares of Abivax hit the stratosphere Wednesday after the firm unveiled "potentially disruptive" results for its ulcerative ...

The upward revision in Skyrizi guidance more than offsets the reduced outlook for Humira guidance. AbbVie now expects U.S.

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is often perceived as a condition ...

A new study shows that a healthy, plant-based diet could reduce your risk of inflammatory bowel disease by 14%.

Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...

The research was conducted by the Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES 21) consortium, ...

The research was conducted by the Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES 21) consortium, a group of international IBD and public health experts led by Gilaad G.